Glucose Health, Inc.

The current price of GLUC is 0.5000 USD — it has increased by 14.94% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Glucose Health, Inc. stocks are traded under the ticker GLUC.

GLUC stock is 16.50% volatile and has beta coefficient of 1.22. Check out the list of the most volatile stocks — is Glucose Health, Inc. there?

Yes, you can track Glucose Health, Inc. financials in yearly and quarterly reports right on TradingView.

GLUC stock hasn't changed in a week, the month change is a 23.07% fall, over the last year Glucose Health, Inc. has showed a 22.25% increase.

GLUC net income for the last quarter is ‪−152.71 K‬ USD, while the quarter before that showed ‪−47.71 K‬ USD of net income which accounts for −220.09% change. Track more Glucose Health, Inc. financial stats to get the full picture.

No, GLUC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, GLUC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Glucose Health, Inc. stock right from TradingView charts — choose your broker and connect to your account.

GLUC reached its all-time high on Jan 5, 2021 with the price of 8.9800 USD, and its all-time low was 0.0274 USD and was reached on Feb 10, 2016.
See other stocks reaching their highest and lowest prices.

As of Apr 25, 2024, the company has 1.00 employees. See our rating of the largest employees — is Glucose Health, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Glucose Health, Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Glucose Health, Inc. stock shows the sell signal. See more of Glucose Health, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Glucose Health, Inc. EBITDA is ‪−421.95 K‬ USD, and current EBITDA margin is −78.91%. See more stats in Glucose Health, Inc. financial statements.